The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA takes first step in possible reversal of ban on some peptides The Washington Post Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law FDA to weigh easing limits on unproven peptides